“Monitoring Kidney Function Through the Use of Candesartan, Telmisartan or Valsartan Antihypertensive Therapy towards Patients CKD” (2022) Media Kesehatan Masyarakat Indonesia, 18(1), pp. 1–9. doi:10.30597/mkmi.v18i1.17780.